These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32030543)

  • 1. The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.
    Morselli C; Boari N; Artico M; Bailo M; Piccioni LO; Giallini I; de Vincentiis M; Mortini P; Mancini P
    Neurosurg Rev; 2021 Feb; 44(1):223-238. PubMed ID: 32030543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cochlear implantation after radiosurgery for vestibular schwannoma.
    Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
    J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous cochlear implantation as a therapeutic option in vestibular schwannoma surgery: case report.
    Dos Santos Neto PH; Zamponi JO; Hamerschmidt R; Wiemes GRM; Rassi MS; Borba LAB
    Neurosurg Focus; 2018 Mar; 44(3):E9. PubMed ID: 29490548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlea radiation dose correlates with hearing loss after stereotactic radiosurgery of vestibular schwannoma.
    Hayden Gephart MG; Hansasuta A; Balise RR; Choi C; Sakamoto GT; Venteicher AS; Soltys SG; Gibbs IC; Harsh GR; Adler JR; Chang SD
    World Neurosurg; 2013; 80(3-4):359-63. PubMed ID: 22484770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery.
    Hassepass F; Arndt S; Aschendorff A; Laszig R; Wesarg T
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2373-83. PubMed ID: 26498948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions.
    Jacob JT; Carlson ML; Schiefer TK; Pollock BE; Driscoll CL; Link MJ
    Neurosurgery; 2014 May; 74(5):466-74; discussion 474. PubMed ID: 24476904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hearing preservation in patients with vestibular schwannoma treated with Gamma Knife surgery.
    Baschnagel AM; Chen PY; Bojrab D; Pieper D; Kartush J; Didyuk O; Naumann IC; Maitz A; Grills IS
    J Neurosurg; 2013 Mar; 118(3):571-8. PubMed ID: 23216466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translabyrinthine vestibular schwannoma resection with simultaneous cochlear implantation.
    DeHart AN; Broaddus WC; Coelho DH
    Cochlear Implants Int; 2017 Sep; 18(5):278-284. PubMed ID: 28602150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
    Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
    Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestibular schwannoma in the only hearing ear: role of cochlear implants.
    Di Lella F; Merkus P; Di Trapani G; Taibah A; Guida M; Sanna M
    Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):91-9. PubMed ID: 23534123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear implant rehabilitation for patients with vestibular schwannoma: report of two cases.
    Amoodi HA; Makki FM; Cavanagh J; Maessen H; Bance M
    Cochlear Implants Int; 2012 May; 13(2):124-7. PubMed ID: 22152982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
    Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
    Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.